Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

41.31
+0.30020.73%
Volume:3.47M
Turnover:142.80M
Market Cap:16.14B
PE:-5.13
High:41.71
Open:41.10
Low:40.17
Close:41.01
52wk High:55.20
52wk Low:22.28
Shares:390.68M
Float Shares:363.29M
Volume Ratio:0.42
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0516
EPS(LYR):-9.2734
ROE:-29.32%
ROA:-15.49%
PB:1.73
PE(LYR):-4.45

Loading ...

Earning Preview: Moderna, Inc. Q4 revenue is expected to decrease by 33.60%, and institutional views are cautiously negative

Earnings Agent
·
Feb 06

Moderna (MRNA) Gets a Sell from Bank of America Securities

TIPRANKS
·
Yesterday

Why Moderna (MRNA) Is Down 6.9% After Judge Lets US$5 Billion Patent Lawsuit Proceed

Simply Wall St.
·
Feb 07

Arbutus Biopharma Corp - U.S. Court Issues Memorandum in Arbutus VS. Moderna Case - SEC Filing

THOMSON REUTERS
·
Feb 07

Mixed options sentiment in Moderna with shares down 1.52%

TIPRANKS
·
Feb 07

Moderna Reports Five-Year Data Showing mRNA Cancer Vaccine Halves Recurrence Risk in Melanoma Trial

Reuters
·
Feb 05

Moderna meldet anhaltenden Therapieerfolg mit intismeran autogene und KEYTRUDA bei Hochrisiko-Melanom

Reuters
·
Feb 05

Ares Management vergibt Milliardenkredit an Moderna zur Wachstumsfinanzierung

Reuters
·
Feb 05

Is Moderna (MRNA) Pricing Reflect Long Term Potential After Recent 36.7% Surge?

Simply Wall St.
·
Feb 04

Analysts Offer Insights on Healthcare Companies: Merck KGaA (GB:0O14) and Moderna (MRNA)

TIPRANKS
·
Feb 04

Option traders moderately bearish in Moderna with shares down 3.89%

TIPRANKS
·
Feb 03

Moderna reverses lower after court issues memo in patent fight with Arbutus

TIPRANKS
·
Feb 03

Moderna Stock Slips As Ambitious Cancer Trials Drag On

TIPRANKS
·
Jan 31

Moderna Inc. Stock Falls 6.0%, Underperforms Peers

Dow Jones
·
Jan 31

These Were the Best and Worst S&P 500 Stocks in January -- Barrons.com

Dow Jones
·
Jan 31

Leerink Partners Adjusts Moderna Price Target to $17 From $18, Maintains Underperform Rating

MT Newswires Live
·
Jan 31

Stock Track | Moderna Stock Plummets 5.05% Intraday Following Departure of Key COVID Vaccine Executive

Stock Track
·
Jan 31

Moderna CMO Jacqueline Miller to step down

Reuters
·
Jan 30

Moderna: David Berman to Join Moderna as Chief Development Officer

THOMSON REUTERS
·
Jan 30

Moderna: DR. Jacqueline Miller Will Step Down as Chief Medical Officer

THOMSON REUTERS
·
Jan 30